bioAffinity Technologies, Inc. (BIAF) vs Universe Pharmaceuticals Inc. (UPC)
A side-by-side comparison of bioAffinity Technologies, Inc. and Universe Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UPC
Universe Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BIAF vs UPC
growth of $100 · dividends reinvested · last 4yBIAF -99.8% (-79.8%/yr)UPC -99.8% (-78.0%/yr)UPC compounded faster over this window
BIAF UPC
BIAF vs UPC: by the numbers
- •UPC is the larger company ($3M vs $3M market cap).
- •Both run net losses; UPC's is the smaller (-20.56% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | BIAF | UPC |
|---|---|---|
| P/S ratio | 0.43 | N/A |
| P/B ratio | 0.67 | 0.05 |
Profitability
| Metric | BIAF | UPC |
|---|---|---|
| Gross margin | 23.21% | 35.28% |
| Operating margin | -171.58% | -16.33% |
| Net margin | -257.33% | -20.56% |
| ROE | -402.92% | -6.54% |
| ROIC | -237.93% | -4.46% |
Growth (annualized)
| Metric | BIAF | UPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.27% |
| Total return CAGR (5Y) | N/A | -78.19% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.